S. 139 · 114th Congress

Ensuring Access to Clinical Trials Act of 2015

Stage
Signed by the president
Sponsor
Ron Wyden
Introduced
2015-01-08
Latest action
2015-10-07 · Signed by President.

Action history

  1. 2015-10-07Signed by President.
  2. 2015-10-07Became Public Law No: 114-63.
  3. 2015-09-30Presented to President.
  4. 2015-09-28Motion to reconsider laid on the table Agreed to without objection.
  5. 2015-09-28On motion to suspend the rules and pass the bill Agreed to by voice vote.
  6. 2015-09-28DEBATE - The House proceeded with forty minutes of debate on S. 139.
  7. 2015-09-28Considered under suspension of the rules.
  8. 2015-09-28Mr. Ryan (WI) moved to suspend the rules and pass the bill.
  9. 2015-07-24Referred to the Subcommittee on Health.
  10. 2015-07-21Referred to the Subcommittee on Health.
  11. 2015-07-20Received in the House.
  12. 2015-07-20Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  13. 2015-07-20Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  14. 2015-07-17Message on Senate action sent to the House.
  15. 2015-07-16Senate Committee on Finance discharged by Unanimous Consent.
  16. 2015-07-16Passed Senate without amendment by Unanimous Consent.
  17. 2015-01-08Introduced in Senate
  18. 2015-01-08Read twice and referred to the Committee on Finance.